Question 1

What is the catalog number for OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued?

Accepted Answer

The catalog number for OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued is 039304-ML405.

Question 2

What sizes are available for OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued?

Accepted Answer

OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued is available in the following size(s): 100 µL.

Question 3

Is OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued in stock?

Accepted Answer

OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 5

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 6

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

OR10G9, CT (OR10G9, OR10G10P, Olfactory receptor 10G9, Olfactory receptor 10G10) (MaxLight 405) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

WIPI2 (2A2), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2744), CF740 conjugate, 0.1mg/mL

Caldesmon, HMW (h-Caldesmon) (h-CALD), CF647 conjugate, 0.1mg/mL

FSH beta (FSHb/1062), CF740 conjugate, 0.1mg/mL

Anti-TREM1 Antibody Picoband®, iFluor647 Conjugate

Anti-FOXO3A Antibody Picoband® (FITC Conjugate)